Growth Metrics

Novavax (NVAX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $205.3 million.

  • Novavax's Non-Current Assets fell 6627.83% to $205.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 4094.57%. This contributed to the annual value of $431.5 million for FY2024, which is 3398.49% down from last year.
  • Novavax's Non-Current Assets amounted to $205.3 million in Q3 2025, which was down 6627.83% from $417.0 million recorded in Q2 2025.
  • Novavax's Non-Current Assets' 5-year high stood at $653.6 million during Q4 2023, with a 5-year trough of $205.3 million in Q3 2025.
  • In the last 5 years, Novavax's Non-Current Assets had a median value of $487.5 million in 2022 and averaged $493.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 39643.31% in 2021, then plummeted by 6627.83% in 2025.
  • Quarter analysis of 5 years shows Novavax's Non-Current Assets stood at $421.6 million in 2021, then surged by 31.7% to $555.3 million in 2022, then increased by 17.71% to $653.6 million in 2023, then crashed by 33.98% to $431.5 million in 2024, then plummeted by 52.42% to $205.3 million in 2025.
  • Its Non-Current Assets was $205.3 million in Q3 2025, compared to $417.0 million in Q2 2025 and $425.0 million in Q1 2025.